Bioinfra Co Ltd
199730
Company Profile
Business description
Bioinfra Co Ltd includes bioequivalence testing of generic drugs, Phase 1 clinical trials for improved new drugs, regulatory approval clinical trials, immunoassays, and pharmaceutical quality testing.
Contact
120 Heungdeokjungang-ro
4th and 5th Floors
Giheung-gu, Yongin-si
Gyeonggi-do16950
KORT: +82 316272800
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
138
Stocks News & Analysis
stocks
Stop asking if there’s a stock market bubble. Ask this instead.
Why earnings growth might be more important when assessing frothy market conditions.
stocks
Are negative AI narratives holding this ASX share back?
This company is unlikely to be disrupted by AI
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,986.20 | 49.10 | -0.54% |
| CAC 40 | 8,402.01 | 34.68 | 0.41% |
| DAX 40 | 24,986.43 | 359.54 | 1.46% |
| Dow JONES (US) | 52,299.44 | 116.70 | 0.22% |
| FTSE 100 | 10,526.20 | 41.98 | 0.40% |
| HKSE | 22,881.02 | 145.66 | -0.63% |
| NASDAQ | 26,048.24 | 228.10 | 0.88% |
| Nikkei 225 | 70,062.32 | 594.21 | 0.86% |
| NZX 50 Index | 13,621.66 | 76.10 | 0.56% |
| S&P 500 | 7,472.31 | 31.88 | 0.43% |
| S&P/ASX 200 | 8,778.70 | 52.80 | -0.60% |
| SSE Composite Index | 4,094.40 | 20.50 | 0.50% |